CC

Christopher F. Claiborne

MP Millennium Pharmaceuticals: 18 patents #27 of 771Top 4%
Merck: 16 patents #667 of 9,382Top 8%
SR Scripps Research: 2 patents #437 of 1,293Top 35%
📍 Cambridge, MA: #214 of 8,183 inventorsTop 3%
🗺 Massachusetts: #2,153 of 88,656 inventorsTop 3%
Overall (All Time): #89,144 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 1–25 of 37 patents

Patent #TitleCo-InventorsDate
11958855 Aurora kinase inhibitors for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2024-04-16
11014928 Compounds and methods for inhibiting mitotic progression Lloyd J. Payne, Richard J. Boyce, Todd B. Sells, Stephen G. Stroud, Stuart Travers +2 more 2021-05-25
10836766 Aurora kinase inhibitors for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2020-11-17
10414770 Compounds and methods for inhibiting mitotic progression Lloyd J. Payne, Richard J. Boyce, Todd B. Sells, Stephen G. Stroud, Stuart Travers +2 more 2019-09-17
9988384 Aurora kinase inhibitors for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2018-06-05
9765076 Aurora kinase inhibitors for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2017-09-19
9765078 Compounds and methods for inhibiting mitotic progression Lloyd J. Payne, Richard J. Boyce, Todd B. Sells, Stephen G. Stroud, Stuart Travers +2 more 2017-09-19
9718788 Heteroaryl compounds useful as inhibitors of E1 activating enzymes Stephen Critchley, Steven P. Langston, Hirotake Mizutani, Edward J. Olhava, Stephane Peluso +2 more 2017-08-01
9458108 Heteroaryl compounds useful as inhibitors of E1 activating enzymes Stephen Critchley, Steven P. Langston, Hirotake Mizutani, Edward J. Olhava, Stephane Peluso +2 more 2016-10-04
9150525 Heteroaryl compounds useful as inhibitors of E1 activating enzymes Stephen Critchley, Steven P. Langston, Hirotake Mizutani, Edward J. Olhava, Stephane Peluso +2 more 2015-10-06
9102678 Compounds and methods for inhibiting mitotic progression Lloyd J. Payne, Richard J. Boyce, Todd B. Sells, Stephen G. Stroud, Stuart Travers +2 more 2015-08-11
8481550 Heteroaryl compounds useful as inhibitors of E1 activating enzymes Stephen Critchley, Courtney A. Cullis, Steven P. Langston, Hirotake Mizutani, Edward J. Olhava +4 more 2013-07-09
8338449 Isoquinolinone potassium channel inhibitors B. Wesley Trotter, Gerald S. Ponticello, Charles J. McIntyre, Nigel J. Liverton, David A. Claremon 2012-12-25
8026246 Aurora kinase inhibitors for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2011-09-27
8008307 Heteroaryl compounds useful as inhibitors of E1 activating enzymes Stephen Critchley, Courtney A. Cullis, Steven P. Langston, Hirotake Mizutani, Edward J. Olhava +4 more 2011-08-30
7935694 Lactam compounds useful as protein kinase inhibitors Christopher Blackburn, Courtney A. Cullis, Natalie Dales, Michael A. Patane, Matthew Stirling +2 more 2011-05-03
7723352 Isoquinolinone potassium channel inhibitors B. Wesley Trotter, Gerald S. Ponticello, Charles J. McIntyre, Nigel J. Liverton, David A. Claremon 2010-05-25
7718648 Pyridobenzazepine compounds and methods for inhibiting mitotic progression Todd B. Sells, Stephen G. Stroud 2010-05-18
7592360 3-fluoro-piperidines as NMDA/NR2B antagonists Nigel J. Liverton, David A. Claremon, John A. McCauley 2009-09-22
7572784 Compounds and methods for inhibiting mitotic progression Lloyd J. Payne, Richard J. Boyce, Todd B. Sells, Stephen G. Stroud, Stuart Travers +2 more 2009-08-11
7459448 Lactam compounds useful as protein kinase inhibitors Christopher Blackburn, Courtney A. Cullis, Natalie Dales, Michael A. Patane, Matthew Stirling +2 more 2008-12-02
7375125 Melanocortin-4 receptor binding compounds and methods of use thereof Tricia J. Vos, Michael Solomon, Martin P. Maguire, Mingshi Dai, Michael A. Patane +1 more 2008-05-20
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists Nigel J. Liverton, John W. Butcher, Charles J. McIntyre, David A. Claremon, John A. McCauley +3 more 2007-08-21
7217716 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists David A. Claremon, Brian Libby, John W. Butcher, John A. McCauley, Nigel J. Liverton +4 more 2007-05-15
7053089 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists John W. Butcher, David A. Claremon, Brian Libby, Nigel J. Liverton, Peter M. Munson +4 more 2006-05-30